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Abstract
The Notch protein is one of the most mechanistically direct transmembrane receptors – the 
intracellular domain contains a transcriptional regulator that is released from the membrane when 
engagement of the cognate extracellular ligand induces intramembrane proteolysis. We find that 
chimeric forms of Notch, in which both the extracellular sensor module and the intracellular 
transcriptional module are replaced with heterologous protein domains, can serve as a general 
platform for generating novel cell-cell contact signaling pathways. Synthetic Notch (synNotch) 
pathways can drive user-defined functional responses in diverse mammalian cell types. Because 
individual synNotch pathways do not share common signaling intermediates, the pathways are 
functionally orthogonal. Thus multiple synNotch receptors can be used in the same cell to achieve 
combinatorial integration of environmental cues, including Boolean response programs, multi-
cellular signaling cascades, and self-organized cellular patterns. SynNotch receptors provide 
extraordinary flexibility in engineering cells with customized sensing/response behaviors to user-
specified extracellular cues.
INTRODUCTION
In the emerging areas of synthetic biology and cell engineering, a fundamental goal is to be 
able to rationally change what extracellular cues a cell recognizes, as well as the resulting 
cellular response. Customized cell sensing/response pathways would be extremely useful for 
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engineering therapeutic cells, allowing them to autonomously sense user-specified disease or 
injury signals, and to precisely deploy therapeutic or repair functions (Fischbach et al., 2013; 
Lienert et al., 2014; Slomovic et al., 2015). Customized cell sensing/response behaviors 
would also be useful tools for reporting on cell connectivity and environmental conditions. 
Novel cell-cell communication channels could also enable design of multicellular 
assemblies whose self-organization could be driven by specific cell-cell signaling networks. 
For these purposes we would like to have synthetic pathways for which input and output can 
be flexibly altered in a modular fashion. In addition, it would be ideal for such synthetic 
pathways to function orthogonally from endogenous pathways and one another, allowing for 
combinatorial input integration with little crosstalk.
Eukaryotic cells have evolved diverse transmembrane receptors that allow them to recognize 
extracellular molecules and induce intracellular responses. In most cases, the extracellular 
engagement of these receptors allosterically regulates an associated intracellular enzymatic 
activity (e.g. kinase or guanine nucleotide exchange factor) (Lim et al., 2014). The resulting 
enzyme and its substrates then transduce signals to various downstream modules, including 
transcriptional regulators that mediate global cellular response programs. It is challenging to 
rationally alter these complex enzyme-linked receptors and their downstream cascades in a 
way that leads to completely novel and orthogonal input/output linkages.
Thus, to generate synthetic pathways that would allow customizable sensing and response 
engineering, we turned to the Notch pathway, which is unique because of its very direct and 
simple mechanism of signal transduction (Kopan, 2002). Engagement of the Notch receptor 
with its ligand – Delta family proteins that are presented on the surface of partner cells – 
leads to intramembrane proteolysis (sequential proteolysis by ADAM metalloprotease and 
the gamma-secretase complex; Kopan and Ilagan, 2009). The induced cleavage of the 
receptor releases the intracellular fragment of Notch (Fig. 1A). This Notch intracellular 
domain is a transcriptional regulator that can only function when it is released from the 
membrane and can enter the nucleus to activate target genes that play key roles in cell-cell 
signaling during development (Artavanis-Tsakonas et al., 1999).
While the Notch proteolytic mechanism of sensing probably does not lead to significant 
signal amplification, it does appear to be quite flexible. Prior studies have demonstrated that 
the intracellular domain of Notch can be replaced with an artificial transcription factor (e.g. 
Gal4-VP64) to create a reporter of Notch activity (Lecourtois and Schweisguth, 1998; Struhl 
and Adachi, 1998) (Fig. 1A). Studies of the physical mechanism of Notch activation have 
also shown that the extracellular domain of Notch can be replaced by alternative domains 
(Gordon et al., 2015). The very direct mechanism of Notch signaling has also inspired the 
engineering of novel proteolytically induced receptors and reporter systems (Barnea et al., 
2008; Daringer et al., 2014).
Given the apparent modularity of Notch receptors, we explored whether the Notch receptor 
could be used as a platform to generate synthetic signaling pathways in which both sensing 
and response were customized (Fig. 1A). Here we show that we can customize input sensing 
by swapping the extracellular recognition domain of these receptors, including the use of 
antibody-based domains (e.g. single-chain antibodies or nanobodies) to detect a wide range 
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of user-specified cell surface proteins, such as disease antigens. Simultaneously, we can link 
these novel inputs to customized responses, by swapping the intracellular transcription 
domain and providing specific downstream effector target genes. The resulting synthetic 
Notch receptors only retain the minimal transmembrane core domain of the native Notch, 
which mediates control of proteolysis. These synthetic Notch receptors function in a range 
of cells, including immune cells and neurons.
Using synthetic Notch pathways, we can spatially direct induction of complex responses 
such as differentiation and pattern formation. We also show that synthetic Notch receptors, 
as long as they have distinct intracellular and extracellular domains, function orthogonally to 
one another, since they then share no common signaling intermediates. Thus, multiple 
synthetic Notch pathways can be deployed in the same cell, and can be used to engineer 
complex combinatorial sensing circuits. The flexibility of synthetic Notch receptors in 
engineering novel cell behaviors makes them powerful tools for constructing therapeutic 
cells (see companion paper, Roybal et al.), driving formation of complex multicellular 
patterns, or for modulating or reporting on cellular behavior in a complex in vivo milieu.
Synthetic Notch receptors, with their customizable input/output function, add a powerful and 
flexible sensing functionality to the mammalian synthetic biology toolbox. The great variety 
of synthetic intracellular transcriptional circuits that have previously been engineered can 
now be linked to the outside of the cell and controlled by user-defined extracellular inputs.
RESULTS
Minimal Notch regulatory domain can be combined with novel extra- and intra-cellular 
domains to construct diverse synthetic receptors
Although the Notch receptor is a large multidomain protein, the regulatory core of the 
receptor is centered around the transmembrane region, where the proteolytic cleavages take 
place to release the intracellular transcriptional domain (Gordon et al., 2007). Prior studies 
indicate that the intracellular and extracellular domains of Notch can be replaced (Gordon et 
al., 2015; Lecourtois and Schweisguth, 1998; Struhl and Adachi, 1998). Thus, we reasoned 
that this regulatory core could potentially be used as a platform for engineering diverse 
synthetic receptors in which both the extracellular input domain and then intracellular output 
domain were simultaneously changed (Figure 1B).
We generated libraries of receptor molecules with different extracellular domains each 
coupled with a different intracellular domain, and expressed them in fibroblasts, along with 
their downstream response elements (Figure 1B). We found that these synthetic receptors 
are strongly activated by cell-cell contact with sender cells expressing the cognate ligand on 
their membrane and by surface-bound ligand (Figure S1A and Figure 2A). For example, a 
synthetic Notch receptor containing an extracellular single chain antibody (scFv) for the B 
cell surface antigen CD19, shows no basal transcriptional reporter activity, but can be 
potently activated by stimulating with CD19 expressing cells. Similarly strong activation is 
also observed by a synthetic Notch receptor containing an extracellular anti-GFP nanobody: 
cells expressing this receptor show strongly induced reporter transcription when stimulated 
with sender cells with surface expressed GFP (Fig. S1A). To determine if the activation of 
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synNotch receptors occurred by a cleavage mechanism similar to endogenous Notch, we 
tested the effect of blocking the gamma-secretase protease using the drug N-[N-(3,5-
difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl ester (DAPT). Treatment with DAPT 
completely blocks synNotch activation (Figure 2A).
A large number of the extracellular domains that we used yielded functional receptors (Fig. 
S1A), but for certain extracellular domains, we observed poor inducibility (e.g. α-integrin, 
E-cadherin, Ephrin), or high background activity, as was the case with a receptor with an 
scFv domain that recognized the tumor antigen mesothelin. We discovered that, by slightly 
extending the core Notch regulatory region to include one or more extracellular EGF-
repeats, we could improve synthetic receptor function that would otherwise display high 
basal activation. The anti-mesothelin receptor displayed low basal activation when this 
extension was incorporated, but still was strongly activated upon stimulation (Figure S1B). 
In general, adding the EGF repeat decreased the basal activation of receptors, without 
reducing the induced state. Another way to control the output of these synthetic receptors is 
by changing the amount of receptor expressed, since the magnitude of induction correlates 
with expression (Fig. S1C).
The dose/response relationship between the ligand concentration and the receptor activation 
is graded, replicating a feature of the endogenous Notch signaling (Sprinzak et al., 2010) 
(Fig. S2A). We also characterized the dynamics of synNotch activation and found that 
significant transcriptional activity resulted from activation pulses as short as 1 hr (Fig. S2C). 
The synthetic receptor response is also reversible upon removal of the ligand expressing 
cells over a timescale of several hours (Fig. S2B), although the rate of decay will likely be a 
function of the stability of the specific effector proteins that are induced.
We tested the GFP-detecting synNotch receptor against ligands presented in different 
formats – soluble GFP, cell-surface expressed GFP (in trans – i.e. on opposing cell), and cis 
cell surface expressed (i.e. on same cell as the receptor) (Fig. 2C). We found that the 
synNotch receptor only transduces the signal when its ligand is presented on an opposing 
surface; no activation was detected when the cognate ligand was in solution or presented on 
the same surface as the receptor (cis). This is consistent with apparent need for the ligand to 
be presented in a manner that will exert force on the receptor. Interestingly, when the ligand 
is present in cis on the same cell surface that expresses the receptor, the synNotch receptors 
can no longer be activated by ligands presented in trans (Fig. 2C, Fig. S2D), mimicking a 
feature of native Notch known as cis-inhibition (Micchelli et al., 1997).
On the intracellular side, we show that we can use the synNotch platform to induce 
transcriptional repression as well as activation. We generated versions of the receptor with 
an intracellular transcriptional repressor domain (KRAB) fused to a Gal4 DNA-binding 
domain. The cells that express this synNotch receptor respond by down-regulating the 
reporter gene when co-cultivated with sender cells (Figure 2B).
We also inserted other intracellular domains into the synNotch platform, including Cre 
recombinases, and master transcription factors such as MyoD and Snail. While some of 
these showed regulated activity, in general these activities were quite low (data not shown), 
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most likely because the synNotch receptor output domain functions stoichiometrically and 
does not, by itself, undergo amplification. Thus this receptor system seems to work most 
robustly with outputs that are intrinsically highly amplified.
Synthetic Notch receptors work in diverse primary cells: neurons and immune cells
To test if the synNotch receptor could function in diverse cells, we engineered a CD19-
detecting synNotch receptor into a series of cell lines: epithelial MDCK cells, L929 and 
C3H mouse fibroblasts cell lines, HEK293 human epithelial cell lines, and Jurkat T cells. 
All of these cells showed clear induction of reporter gene activation upon synNotch receptor 
engagement (Fig. 3B, 4A–B, S1A). Importantly, we also showed that synNotch receptors 
could function in primary cells: primary hippocampal neurons that express the anti-CD19 
synNotch can be induced to express a GFP reporter by contact with CD19-expressing sender 
cells (Figure 3A, Fig. S3). We also show in the accompanying paper that synNotch receptors 
function in primary human immune cells, and can act within the setting of live animals 
(Roybal et al.). These results indicate that a wide variety of cells have the necessary 
proteolytic machinery for synNotch activation.
Synthetic Notch receptors can induce cell fate changes in a spatially controlled manner
SynNotch receiver cells can detect whether a contacting cell is expressing the ligand or not. 
We tested if the contact-dependent feature of the signaling can be used to induce highly 
local, spatially controlled responses. Control of cell response with a short-range signaling 
channel, such as synNotch, would, in principle, allow the user to specify cell behavior in a 
highly localized manner within a multicellular tissue. We first tested whether synNotch 
receiver cells placed in an epithelial cell layer could be spatially induced to express a 
reporter gene. To do so, we plated a confluent layer of epithelial cells expressing the anti-
GFP synNotch receptor (receivers), seeding the layer with a small number of GFP 
expressing cells (senders). As shown in Figure 4A, the BFP reporter gene is activated only 
in the receiver cells that are in direct contact with the GFP expressing sender cells, forming a 
blue ring pattern around each island of GFP cells. In this way, the monolayer of receiver 
cells is patterned in two cell populations, an activated population that highlights the 
boundary of the islands of sender cells, and an inactive population comprising all the cells in 
between the islands of sender cells.
We then wanted to test whether this synthetic cell-cell signaling could be used to regulate 
cell fate in a spatially controlled manner. We asked whether synNotch receptors could be 
used to induce transdifferentiation of fibroblasts to myoblasts, by inducing expression of 
MyoD, the prototypical master transcription factor for myogenesis (Davis et al., 1987). We 
engineered fibroblasts to express an anti-CD19 synNotch receptor with a tTa intracellular 
domain, along with the myoD gene expressed from the cognate tetracycline response 
element (TRE) promoter. We also engineered sender fibroblasts expressing the CD19 
surface ligand. To test for spatial cell fate induction, we plated a small spot of sender cells, 
and then overlaid these with a confluent layer of the synNotch receiver cells. We found that 
only the synNotch receiver fibroblasts in contact with the cognate cells (blue cells in Fig. 
4B) induced the expression of MyoD (detected via a fused GFP label). The induced 
expression of MyoD led to localized transdifferentiation and the formation of myotubes over 
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the course of ~2 days (Figure 4B and S4A; see Supplemental Movie 1 for time-course). 
Thus we observed spatially directed differentiation into myotubes.
In another example, we demonstrated that synNotch could be used to control epithelial-to-
mesenchymal transitions (EMT). Here we used the anti-GFP synNotch receptor to control 
expression of the EMT master regulator gene, Snail (Cano et al., 2000). In these 
experiments, epithelial receiver cells (MDCKs) have the anti-GFP synNotch that induces 
expression of Snail from a TRE promoter. We can induce EMT in these receiver cells by 
exposing them to cells expressing the cognate ligand – surface displayed GFP (Figure 4C 
and S4B). The observed dissociation of the receiver cells (Fig. 4C) is mirrored by a 
downregulation of cadherin expression (Fig. S4B). The induction of EMT in receiver cells is 
not observed when they are exposed to control sender cells that do not express surface GFP 
(Fig. S4B).
Synthetic Notch pathways are orthogonal to each other and native Notch
We wanted to explore whether multiple synNotch receptors could function within the same 
cell without crosstalk. Orthogonal function would allow a cell to elaborate different outputs 
according to the presence or absence of multiple inputs. We hypothesized that synNotch 
receptors might function orthogonally to one another because of their very simple 
mechanism of signaling – there are no common intermediates (e.g. an activated kinase or 
kinase substrates) that could yield cross-talk, as long as the intracellular transcriptional 
regulators in the different receptors are distinct. We first tested if there was any cross talk 
between the synNotch and the endogenous Notch signaling. We used one version of Notch 
containing the full endogenous extracellular domain (which recognizes the natural ligand 
Delta) and a tTa intracellular transcriptional domain. This receptor drives GFP expression. 
We also used a second synNotch receptor that recognizes CD19, and drives tagBFP 
expression (via intracellular Gal4-VP64 transcriptional domain). We engineered fibroblasts 
to express both receptor systems simultaneously. When we stimulated the receiver cells with 
only Delta, only the full-length-Notch reporter (GFP) was activated. When the same receiver 
cells were stimulated with sender cells expressing CD19 (the synNotch ligand), the receiver 
cells only induced the synNotch reporter tagBFP. Both reporters are induced with dual 
ligand stimulation. Thus the synNotch and the endogenous Notch pathways display 
independent but compatible activation (Figure 5A and S5A).
We then tested whether two different synNotch pathways could function independently in 
the same cell. To do that, we engineered double synNotch receiver cells with both an anti-
CD19 receptor and an anti-GFP receptor, each linked to a different intracellular transcription 
activation domain (Gal4-VP64 and tTA respectively) that in turn drives a distinct reporter 
fluorescent protein (mCherry and tagBFP respectively). In Figure 5B we show the results of 
stimulation of the double-synNotch receiver cells with cells expressing the two ligands 
CD19 and GFP separately or combined. When activated by CD19, only the anti-CD19-
synNotch response is activated. Conversely, when activated by GFP-expressing sender cells, 
only the anti-GFP-synNotch response is activated. Importantly, when the cells are stimulated 
by both input ligands (CD19 and GFP) the two responses are activated together (Fig. 5B and 
S5B). Thus multiple synNotch pathways can work in the same cell as insulated and 
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independent signal transduction pathways, enabling us to engineer cells that respond to 
multiple stimuli with distinct user-defined transcriptional programs.
Multiple synNotch receptors can be used to engineer cells that combinatorially integrate 
multiple inputs
We showed that multiple synNotch receptors can be used in the same cell to generate 
independent responses with no crosstalk. Thus we reasoned that we could use these 
receptors to engineer cells that integrate combinatorial environmental cues and respond only 
when certain dual criteria are met. In particular, we focused on the generation of cells that 
would respond only in the presence of two different contacting extracellular ligands (not 
responding to each ligand alone). We thus engineered cells that expressed both the anti-
CD19 and anti-GFP synNotch receptors. But in this case, each receptor controls one half of 
a split transcription factor (Luan et al., 2006) – the anti-CD19 synNotch receptor drives 
expression of a Gal4 DNA binding domain fused to a leucine zipper dimerization domain, 
while the anti-GFP synNotch receptor contains as its intracellular domain the VP64 
transcriptional activation domain fused to a complementary leucine zipper dimerization 
domain. To report on the presence of a fully functional Gal4 DBD-zipper:zipper-VP64 
complex, these cells also contain a reporter gene (mCherry) under control a Gal4 UAS 
promoter (Fig. 5C). These double synNotch cells were stimulated with sender cells 
expressing either one or both of the input ligands. When a single input is presented to the 
receiver cells, no activation is visible (Figure 5C, columns 1–3). Only when the sender cells 
express both the antigens was the response in receiver cells induced (Figure 5C, last 
column). Thus we can use synNotch receptors in this type of split output circuit architecture 
to construct cellular AND-gate pathways that are dependent on the concomitant stimulation 
with two combinatorial inputs.
Engineering cascades of cell-cell signaling with multiple synNotch receptors
With multiple synNotch receptors, we should also be able to generate more complex pattern 
formation circuits involving cascades of cell-cell communication. Here we focused on 
inducing a self-organized multi-layer spatial pattern in epithelial cells. For this experiment, 
we constructed receiver cells expressing two different synNotch receptors that could 
potentially act in series – the first receptor induces the expression of the ligand for the 
second receptor. In particular, we used the anti-GFP-synNotch receptor to induce CD19 
ligand expression (as well the reporter protein mCherry), and the anti-CD19-synNotch 
receptor to induce the reporter protein tagBFP.
To then start the induction of the cell-cell signaling cascade, GFP sender cells were seeded 
sparsely in a monolayer of the double synNotch receiver cells (Fig. 6). We observed that 
within the first day of plating the cells, the neighbors closest to the GFP sender cells become 
red (mCherry) reporting on the activation of the anti-GFP-synNotch (Fig. 6A, DAY 1). This 
first layer of receiver cells is also simultaneously inducing the expression of surface CD19. 
The second layer of receiver cells can then detect the CD19 that is now expressed on the 
first layer of receiver cells. In response, the second layer of receiver cells induces activation 
of the tagBFP reporter (via their anti CD19 synNotch receptor) (Figure 6A, DAY 2).
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This engineered cascade of cell-cell interactions ultimately generates a double-ring pattern 
of red first (mCherry), and then blue (tagBFP) receiver cells around the green sender cells 
(GFP) (Fig. 6B). In this way, two different cell types are dynamically produced in a spatially 
controlled manner within an otherwise identical population of receiver cells (Fig. 6C). Thus, 
multiple synNotch receptors can be used to engineer complex, multistep cell-cell signaling 
cascades that result in pattern formation, akin to what is observed in natural developmental 
programs.
DISCUSSION
Modularity of the Notch receptor and the mechanism of synNotch signaling
We have demonstrated that it is possible to engineer highly diverse forms of synthetic Notch 
receptors, for which one can change what contact ligands the cell detects, and what cellular 
responses occur upon engagement. Inputs are specified by what extracellular recognition 
domain is used, while outputs are determined by what intracellular transcriptional regulator 
is used and what effector genes this regulator drives. The wide variety of possible synNotch 
receptor architectures and domain combinations yields powerful and highly flexible tools for 
engineering cell-cell communication. We demonstrate that cells expressing the synNotch 
receptors are sensitive to new inputs and perform diverse user-defined actions when the cells 
are stimulated by these new inputs. SynNotch receptors can be used to drive diverse output 
functions, including transcriptional activation, repression, and differentiation. Moreover, 
because these interactions are, like the endogenous Delta-Notch interaction, dependent on 
direct cell-cell contact, the regulatory responses generated by synNotch receptors yield 
precise spatial control. SynNotch receptors work in a wide variety of cell types, consistent 
with the widespread expression of the required regulatory proteases that mediate Notch 
cleavage.
These new receptors highlight the extraordinary functional modularity of the Notch receptor. 
Endogenous Notch is composed of three parts: an extracellular ligand-binding domain, a 
regulatory domain (including the transmembrane region) where the core signal transduction 
occurs, and the intracellular effector domain. Work by Blacklow and colleagues suggests 
that transduction in the core Notch regulatory region occurs through a physical pulling 
mechanism (Gordon et al., 2007; 2015). Within the core regulatory region, directly adjacent 
to the transmembrane region, are three Lin-12 Notch Repeats (LNRs), which in the basal 
state bind and shield the ADAM/TACE protease cleavage site (the initial of two protease 
cleavage events required to ultimately release the intracellular domain of Notch). Pulling 
forces generated by binding of the extracellular domain to a ligand presented on an opposing 
cell surface are thought to release the LNR domains, exposing the ADAM/TACE protease 
cleavage site. The protease, which is constitutively active in the membrane, can then initiate 
the cleavage and activation of Notch.
One of the sources of the pulling force in Notch/Delta is thought to be the endocytosis of the 
Delta ligand in the sender cells (Pratt et al., 2011; Yamamoto et al., 2010). It is unclear 
whether ligand endocytosis is required for synNotch receptor activation, since surface bound 
ligands are sufficient for activation, and we do not observe the need to include endocytosis 
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motifs in the ligand constructs. It is possible, however, that endocytosis does in some cases 
contribute to stronger activation of certain synNotch receptors.
We hypothesize that in synNotch receptors, the autoinhibition within the regulatory region is 
maintained, but that engagement of the chimeric extracellular domain to a surface displayed 
ligand is sufficient to pull and displace this autoinhibition, exposing the cleavage site (Fig. 
7A). Given this model, it is not surprising that for some extracellular recognition domains, it 
may be necessary to optimize the receptor by extending or contracting the linker between 
the extracellular and regulatory domains – proper accessibility and force extension to the 
regulatory domain will likely have some geometric constraints. Nonetheless, we show that 
extracellular domains ranging from a single chain antibody to a small peptide epitope, can 
function as the synNotch recognition domain.
Evolution of Notch signaling
It is striking that despite this remarkable modularity, there is not a wide range of naturally 
occurring Notch receptor homologs that mimic the diversity of synNotch receptors that we 
can construct. Unlike tyrosine kinase receptors (of which humans have ~50 diverse family 
members), there are only 1–4 closely related versions of Notch in most metazoan species 
(Blume-Jensen and Hunter, 2001; Kovall and Blacklow, 2010). Thus although this receptor 
has a high degree of potential functional modularity, this modularity appears to have been 
almost completely untapped by evolution, at least in species that have been sequenced (there 
are, however, many mechanisms to modulate both Delta and Notch). It is possible that since 
Notch-Delta signaling functions only through highly localized direct cell contact, there was 
actually less need for a highly diversified set of non-crossreacting ligand-receptor pairs, as is 
the case of soluble signaling systems. Notch-Delta can and is heavily reused by diverse cell 
pairs during development.
We have noted that pre-multicellular organisms, such as choanoflagellates and capsaspora, 
have highly simplified versions of Notch that are similar to the core of synNotch (Fig. 7B) – 
in particular they lack the large extracellular domain of metazoan Notch that is necessary to 
recognize Delta (Gazave et al., 2009). These pre-metazoan species also lack Delta, leading 
to the hypothesis that perhaps other quite different interactions might regulate this proto-
Notch molecule. It has been speculated that the evolution of the modern Notch-Delta 
signaling pair was one of the drivers of modern metazoan multicellularity (Gazave et al., 
2009; King et al., 2008). It is interesting that going back to a core framework that is similar 
to the extremely simplified ancestral Notch, we are able to then re-elaborate the system 
using alternative extracellular and intracellular domains to design highly diverse user-
defined cell-cell interactions.
New capabilities in engineering custom extracellular sensing and response programs
A major goal in synthetic biology is the predictive forward design and control of cell 
behavior. Because of the highly modular nature of transcriptional regulatory components, 
many synthetic biology efforts in the last decade have focused on engineering very 
sophisticated transcriptional circuits (Purnick and Weiss, 2009). On the other hand, tissue 
engineers have focused on engineering extracellular scaffolds or stimulation protocols that 
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can influence cell fate and behavior by tapping into through endogenous cell surface 
receptors (Huch and Koo, 2015; Sasai, 2013; Webber et al., 2014). What has been missing is 
an easily customizable way to link changes in intracellular signal processing to user-defined 
extracellular signals. Linking novel extracellular inputs to intracellular decisions is 
extremely challenging because there are limited ways to transmit extracellular information 
across the plasma membrane. This task is particularly daunting if one wants to build a 
system that is orthogonal to endogenous signaling receptors.
Initial successes in receptor engineering have come from focused efforts often based on 
surgical mutational changes. Recently, more modular solutions for engineering new 
extracellular sensing have emerged. For example, chimeric antigen receptors (CARs) have 
been developed that link an extracellular antigen sensing antibody domain with internal 
signaling domains from the T cell receptor. With the CAR system, the researchers are now 
able to link novel user-specified disease antigen inputs to synthetic activation of the native 
T-cell activation program - these engineered T cells can kill tumor cells that express the 
cognate antigen, and have proven to be clinically effective for B cell cancers (Miller and 
Sadelain, 2015). Despite the power of CARs, these still represent changing only the INPUT 
that the cell senses - the OUTPUT is still the full T cell activation program.
The synNotch receptors therefore bring engineering of extracellular sensing by mammalian 
cells to a new level. Not only can one use them to flexibly detect new inputs, but because the 
output domain and response are also highly modular, the overall response that can be 
generated can also be highly customizable. We show in the accompanying manuscript 
(Roybal et al.) how this flexibility can be used to engineer novel, highly customized T cell 
response behaviors. Overall we believe that synNotch receptors may prove to be very useful 
in therapeutic cells, such as engineered immune cells and in regenerative medicine, both of 
which require specific sensing of environmental signals linked to precise cellular responses. 
These receptors may also prove to be useful tools for mapping cell interactions during 
development or in the brain. The fact that we can generate many orthogonal versions makes 
them highly extensible for mapping multiple interactions. These synthetic receptors may 
also prove to be useful tools for systematically perturbing particular cell-cell interactions to 
better understand complex developmental processes.
MATERIAL AND METHODS
SynNotch Receptor and Response Element Construct Design
SynNotch receptors were built by fusing the CD19 scFv (Grupp et al., 2013), mesothelin 
scFv (Chowdhury et al., 1998), LaG17 (lower affinity), or LaG16_2 (high affinity) 
nanobody (Fridy et al., 2014) to the mouse Notch1 (NM_008714) minimal regulatory region 
(Ile1427 to Arg1752) or extended regulatory region (Pro1390 to Arg1752) and Gal4-VP64, 
Gal4-KRAB (Zalatan et al., 2015), tTA (gift from Miki Ebisuya) or ZFHD1 (N205 nLV 
EF-1a-ZFHD1-link-FKBP-HA <T2A> HP1aCS-Frbx2-V5-PGK-Blast was a gift from Jerry 
Crabtree (Addgene plasmid # 44017), (Hathaway et al., 2012)). All synNotch receptors 
contain an N-terminal CD8α signal peptide (MALPVTALLLPLALLLHAARP) for 
membrane targeting and a myc-tag (EQKLISEEDL) for easy determination of surface 
expression with α-myc A647 (cell-signaling #2233). For a list of aminoacid sequences of 
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the constructs used, see Table S1. Full length Notch with tTA intracellular domain and Delta 
are from plasmids from the Ebisuya Lab (Matsuda et al., 2012). All the receptors were 
cloned into a modified pHR’SIN:CSW vector containing a SFFV promoter. The 
pHR’SIN:CSW vector was also modified to make the response element plasmids. Five 
copies of the Gal4 DNA binding domain target sequence 
(GGAGCACTGTCCTCCGAACG), seven copies of the tetracycline responsive element 
(TCCCTATCAGTGATAGAGA) and 4 copies of the ZFHD1 responsive elements 
(TAATGATGGGCG) were cloned 5′ to a minimal CMV promoter. The codon optimized 
cDNA sequence coding for mouse Snail (NP_035557.1), mouse myoD (NP_034996.2), was 
cloned into a MCS downstream of the indicated inducible promoter and 5′ of the indicated 
fluorescent protein reporter. All constructs were cloned via In fusion cloning (Clontech 
#ST0345). The sequences for the split Gal4 transcription factor are from (Luan et al., 2006).
Lentivirus Production
Lentivirus was produced by cotransfecting the pHR plasmids and vectors encoding 
packaging proteins (pMD2.G and p8.91) using the Fugene 6 HD transfection reagent in 
HEK293-T cells plated in 6-well plates at approximately 70% confluence. Viral 
supernatants were collected 2 days after transfection and 0.45 μm filtered. Supernatant was 
used for transduction immediately, stored at 4 degrees for up to 2 weeks, or kept at −80 
degrees for long-term storage.
Cell Lines
L929 mouse fibroblast cells (ATCC# CCL-1), HEK293 cells, C3H/10T1/2 Clone 8 (ATCC# 
CCL-226) were cultured in 10% fetal bovine serum (UCSF Cell Culture Facility) in DMEM 
(Invitrogen) with penicillin, streptomycin and glutamine. MDCK cells were a gift from the 
Mostov Lab at UCSF; they were cultured in MEM (UCSF Cell Culture Facility) with 5% 
fetal bovine serum (UCSF Cell Culture Facility). K562s were lentivirally transduced to 
stably express human CD19 or mesothelin. K562s were also transduced to stably express 
surface GFP (GFP fused to the PDGFR transmembrane domain). All cell lines were sorted 
for expression of the transgenes.
All cell culture were maintained in a humidified incubator at 37% with 5% CO2, and at 
37°C with 5% CO2 in a humidified incubator.
For viral transduction, cells were plated in 6-well dishes to achieve approximately 10% 
confluence at the time of infection. For lentiviral transduction, 10–100 μl of each virus’ 
supernatant was added directly to cells, with polybrene to increase infection efficiency. Viral 
media was replaced with normal growth media 24 hr post infection. Cells were sorted for 
coexpression of each component of the pathways via fluorescence-activated cell sorting on a 
FacsAria2 (Beckton-Dickinson), by staining for the appropriate tag with fluorescently 
tagged antibody where needed. A bulk-sorted population consisting of fluorescence positive 
cells was used for experiment, unless otherwise noted.
For single cell clonal population establishment, single cell were sorted in 96 wells plates 
starting from populations of cells infected with lentiviral particles for the relevant expression 
constructs; the sorting was performed with a FACS ARIA II.
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Neuron Culture
Rat hippocampus neurons are dissected and disassociated from E18 rat embryos, and are 
transected with Lonza Amaxa nucleofector before plating on Poly-D-lysine and Laminin 
coated glass bottomed cell culture dish. Ligand expressing or plain (control) K562 cells are 
plated together with neurons in neural culture medium (neural basal medium supplemented 
with Glutamax, B27 and 5%FBS). Microscope images are taken 4 days after plating.
GFP Purification
For soluble ligand stimulation experiments, green fluorescent protein (GFP) was purified as 
an N-terminal hexahistidine fusion protein. To express protein, BL21(T1R) E. coli cells 
were grown to an OD of 0.6 from a fresh transformation, chilled to 18°C, induced with 0.8 
mM IPTG, and allowed to express overnight. The proteins were purified by Ni-NTA affinity 
chromatography following the manufacturer’s (Qiagen) instructions. The protein was further 
purified by gel-filtration chromatography on a Superdex S200 10/300 equilibrated in PBS. 
The pure fractions were concentrated, aliquoted, flash frozen, and stored at −80 C until use.
Western Blots
For Western Blots, 5×10^6 MDCK cells were plated in wells of a 6-well plate; at 
appropriate time points after stimulation, wells were washed once with ice-cold PBS and 
lysed in 150 μl ice-cold lysis buffer (RIPA buffer, Pierce 89900, and freshly added protease 
inhibitors from Roche Applied Science Cat. #04906837001) and incubated on ice with 
occasional shaking for 5–10 min. Cells and lysis buffer were scraped off each well, collected 
in 1.5 ml Eppendorf tubes and centrifuged at 13,000 g at 4°C for 15 min. 90 μl were 
transferred to screw-top Eppendorf tubes and stored at −80°C.
SDS sample buffer (Novex NuPAGE with 2.5% 2-mercaptoethanol) was added and samples 
were boiled for 5 min and loaded immediately onto gels for western blot processing. Lysates 
were loaded into 4–12% Bis-Tris, 15 well, gels in MOPS buffer (Novex, Life Technologies) 
and run at 90V/140V for a total of 1 hr. Gels were transferred for 1 hr onto nitrocellulose 
membranes using a Trans-Blot semi-dry transfer apparatus (Bio-Rad). Membranes were 
blocked in Odyssey blocking buffer (Li-Cor) for > 1 hr, exposed to diluted primary 
antibodies in Odyssey buffer for 2 hr at room temperature or overnight at 4°C, washed in 
TBST, and exposed to IRDye (Li-Cor) fluorescent anti-rabbit (800CW, 1:15,000) and anti-
mouse (680CT, 1:20,000) secondary antibodies in Odyssey buffer for 1.5 hr at room 
temperature. Membranes were then imaged on a Li-Cor imaging station and band intensities 
quantified in ImageJ. Primary antibodies used were anti-E-cadherin (Cell Signaling #3195 
diluted 1:1000) and anti-alpha-tubulin (Cell Signaling #3873, diluted 1:2000).
Image Analysis
To quantify the profiles of fluorescence intensity in microscope images, the function of NIS 
Elements has been used to average the intensity in a rectangular selection with the width of 
3 pixels.
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Statistical Analysis
Statistical significance was determined by Student’s t-test (two-tailed). All statistical 
analysis and curve fitting was performed with Prism 6 (Graphpad) and p values are reported 
(*** = p ≤ 0.001, **** = p ≤ 0.0001).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Modular Configuration of Synthetic Notch (SynNotch) Receptors
(A) Conceptual design of synNotch receptor systems. Left: wild-type Notch has a large 
extracellular domain that binds to its ligand, Delta, expressed on opposing partner cells, and 
an intracellular transcriptional regulatory domain that is released by ligand induced 
cleavage. Arrows indicate the multiple proteolytic cleavage sites. Middle: Notch reporters 
have been built in which the intracellular domain is replaced by an orthogonal transcription 
factor. Right: in synNotch receptors both the extracellular and intracellular domains have 
been completely replaced, leaving only the small central regulatory region of Notch. Both 
novel inputs and outputs can be defined by using the synNotch architecture.
(B) Modularity of the synNotch platform: the input and output domains from Notch can be 
swapped with diverse domains. On the extracellular side, diverse recognition domains can 
be used (antibody based, or peptide tags are shown) and on the intracellular side, diverse 
effector can be used (transcriptional activators with different DNA-binding domains are 
shown, as well as a transcriptional repressor). See also Figure S1.
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Figure 2. SynNotch Receptors can be used to Program Contact-Dependent Transcriptional 
Regulation
(A) Synthetic Notch receptors can be used to detect endogenous disease antigens and induce 
the expression of a reporter gene. Mouse fibroblasts (L929 line) expressing anti-CD19/tTA 
synNotch are cultivated with K562 sender cells expressing Delta, CD19, or CD19 in the 
presence of the gamma-secretase inhibitor DAPT. FACS plots of the resulting GFP reporter 
intensity in receiver cells are shown. Inset shows an image of MDCK cells expressing the 
anti-CD19→ GFP synNotch, when co-cultivated for 24h with MDCK sender cells 
expressing CD19 (constitutively labeled with tagBFP). Only receiver cells in contact with 
(blue) sender cells activate the reporter and turn green.
Morsut et al. Page 16
Cell. Author manuscript; available in PMC 2017 February 11.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
(B) Mouse fibroblasts (L929 line) with anti-CD19 synNotch with a transcriptional repressor 
intracellular domain (Gal4-KRAB) are co-cultivated with K562 sender cells. The receiver 
cells constitutively express GFP downstream of a SV40/UAS combined promoter. FACS 
plot of receiver cells is shown, in presence of K562 sender cells with or without CD19 
expression, as indicated in figure.
(C) Stimulation of mouse fibroblasts expressing anti-GFP synNotch with ligands in different 
formats. Anti-GFP synNotch receiver cells are stimulated for 1h with GFP either in soluble 
form, presented on a K562 sender-cell, or cis-presented on the receiver cell itself. The 
receiver cells show activation only when the ligand is present on an opposing surface and if 
they do not express the ligand in cis. The FACS data are recorded at 24h after the beginning 
of stimulation. See also Figure S2D for similar data on the anti-CD19 synNotch. FACS 
histograms include at least 10,000 cells for each condition.
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Figure 3. SynNotch Receptors Function in Diverse Cell Types, Including Neurons and 
Lymphocytes
(A) Neurons. Primary hippocampal neurons were dissociated from E18 rat embryos and are 
nucleofected to express an anti-CD19 synNotch → GFP receptor and reporter. Neurons were 
plated on glass-bottom 35mm culture dish coated with Poly-D-Lysine and Laminin. 2 hours 
after neuron plating, sender cells (K562s) are added to the culture. Images are taken from 
live cells at day 4 after plating. On the right, representative images for neurons that are co-
cultured with plain K562 cells (upper panel) or with CD19+ K562 sender cells (bottom 
panel) are shown. Neurons co-cultured with ligand presenting sender cells strongly induce 
GFP expression. See Figure S3 for quantification.
(B) T cell line. Jurkat T clonal cell line engineered to stably express an anti-CD19→ GFP 
synNotch receptor system. Data on the right show fluorescence of clonal Jurkat cell 
population upon stimulation with CD19+ or CD19- sender cells (K562s) at t=24h. T cells 
are activated only when they encounter cell with the cognate ligand. FACS histograms 
include at least 10,000 cells for each condition.
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Figure 4. SynNotch Receptors Yield Spatial Control of Diverse Cellular Behaviors
(A) Boundary detection in epithelial monolayer. Epithelial cells (MDCKs) are engineered as 
follows: sender cells express an extracellular GFP linked to a transmembrane domain; 
receiver cells are a clonal population that express the anti-GFP synNotch with LaG17 anti-
GFP nanobody as extracellular domain, and Gal4-VP64 as intracellular domain, along with 
a UAS→BFP reporter construct. Sender cells are seeded into the receiver cell monolayer at 
a 1:50 ratio. Confocal images are taken 48h after plating of confluent monolayer. 
Representative pictures of high magnification and low magnification are shown, alongside 
with a representative line of intensity of BFP fluorescence over distance. Only receiver cells 
that are in contact with the green sender cells turn on the blue reporter, forming a ring 
around the sender cells. Receiver cells away from sender cells remain uninduced. Scale bars: 
higher magnification 20um; lower magnification 200um.
(B) SynNotch activation of a myogenesis master regulator (myoD) in fibroblasts induces 
transdifferentiation in a spatially controlled manner. C3H mouse fibroblasts are engineered 
as follows: sender cells express extracellular CD19 linked to a transmembrane domain, plus 
a tagBFP marker; receiver cells express the anti-CD19 synNotch with tTA intracellular 
domain, along with a TRE→myoD cassette and a constitutive mCherry marker. Sender 
fibroblasts (blue) are plated first in a limited region of the plate and allowed to adhere to the 
plate; after 1h the receiver cells (red) are plated to uniformly cover the entire glass plate. 
Images show a large area of the co-culture and are still-frames from a movie that span the 
first 48h after co-plating (See also Movie 1). GFP channel shows the induction of myoD-
GFP in received cells in a region that overlaps with the blue channel (sender cells). Receiver 
cells away from sender cells remain uninduced, and provide an internal control for the 
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experiment (See also Figure S4A). A higher magnification of the field for the green channel 
is shown on the right, showing the induction of multinucleate myotubes (scale bar = 50um).
(C) SynNotch can induce epithelial to mesenchymal transition in cultured epithelial cells. 
Epithelial cells (MDCKs) are engineered as follows: receiver cells express the anti-GFP 
synNotch with LaG17 anti-GFP nanobody as extracellular domain, and tTA as intracellular 
domain, along with a TRE→Snail-ires-BFP effector construct. Sender cells are GFP-
expressing K562 cells. Representative bright field microscope images of epithelial cells 
before and after 48h from the addition of sender cells are shown (sender cells were removed 
before imaging). Scale bar = 20um. See Figure S4B for quantification and controls.
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Figure 5. SynNotch Pathways are Orthogonal to One Another and Can be Used for 
Combinatorial Regulation
(A) SynNotch and wild-type Notch activate orthogonal signaling pathways. L929 mouse 
fibroblasts receivers are engineered to express (i) the wild-type Notch receptor with a tTA 
intracellular domain and a TRE→GFP reporter, and (ii) a synNotch receptor with anti-CD19 
extracellular domain and Gal4-VP64 intracellular domain, and a UAS→tagBFP reporter. 
The graph on the right shows the clonal population of receiver cells fluorescence signal for 
the BFP and the GFP reporters in different conditions: black - untreated; blue - stimulated 
with CD19 expressing senders; orange - stimulated with delta senders; and red - stimulated 
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with sender cells expressing both CD19 and delta. Sender cells are mouse L929 fibroblasts. 
See Figure S5A for quantification.
(B) Multiple synNotch receptors are orthogonal to one another. L929 mouse fibroblast 
receiver cells are engineered to express (i) the anti-CD19 synNotch receptor with a tTA 
intracellular domain and a TRE→BFP reporter; and also (ii) the synNotch receptor with 
anti-CD19 extracellular domain and Gal4-VP64 intracellular domain, and a UAS→mCherry 
reporter. The graph on the right shows the receiver cell (clonal population) fluorescence 
signal for the BFP and the mCherry reporters in different conditions: black - untreated cells; 
red - stimulated with CD19 expressing sender cells; green - stimulated with GFP sender 
cells; and blue - stimulated with sender cells expressing both GFP and CD19. Sender cells 
are K562 cells. See Figure S5B for quantification.
(C) Cells engineered with two synNotch AND gate respond only when both the inputs are 
present. L929 mouse fibroblasts receivers are engineered to express: (i) the anti-CD19 
synNotch receptor with a tTA intracellular domain and a TRE promoter that drives the 
expression of the DNA-binding domain (DBD) of Gal4 fused to a leucine zipper domain, 
and (ii) the synNotch receptor with anti-GFP extracellular domain and the VP64 
transcriptional activation domain fused to a complementary leucine zipper as intracellular 
domain, and (iii) a Gal4-responsive promoter driving a red fluorescent protein (mCherry). 
The graph on the right shows the normalized mCherry fluorescence collected from a clonal 
population of receiver cells in co-culture with different sender cells (K562), that express 
either the two ligands alone (GFP or CD19), or both ligands together. Activation occurs only 
in the presence of both the inputs. Data shown are the median and coefficient of variance of 
at least 10,000 cells per condition.
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Figure 6. Multiple SynNotch Receptors can be used to Generate Multi-Layered Self-Organizing 
Epithelial Patterns
Epithelial cells (MDCKs) are engineered as follows: sender cells express extracellular GFP 
linked to a transmembrane domain; receiver cells express two synNotch receptors: (i) the 
anti-GFP synNotch with tTA intracellular domain, along with a TRE→CD19-mCherry 
effector cassette; (ii) the anti-CD19 receptor with Gal4-VP64 intracellular domain, and a 
UAS→tagBFP reporter. Here, the first synNotch receptor, when stimulated, induced the 
expression of the ligand for the second synNotch receptor. (A) Representative images are 
shown for the epithelial layer of sender cells and a clonal population of receiver cells co-
cultivated at a 1:50 ratio for 10h (START) 34h (DAY 1) and 58h (DAY2). Scale bar = 
20um. (B) Multiple images of different fields of view of the co-culture at day 2. Scale bar = 
50um (C) Representative quantification of the fluorescence signal as calculated from the 
fluorescence images for a pattern around sender cells at day 2. Scale bar = 20um.
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Figure 7. Modularity of SynNotch Receptors Expands Sensing/Response Engineering of 
Mammalian Cells
(A) Putative mechanism of activation of the synNotch receptors. As shown by Blacklow and 
others (Gordon et al., 2007), in native Notch, the LNR domains mask the protease cleavage 
site in the unbound conformation (left). When the ligand engages the receptor, mechanical 
force is thought to expose this protease site, initiating the multi-step process leading to 
release of the intracellular transcriptional domain (right). We propose that when the 
extracellular domain is replaced by a novel recognition domain (here an anti-GFP nanobody 
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is shown), then proper cell-cell engagement of the cognate ligand (GFP on the opposing 
cell) can exert a similar force to expose the Notch core to proteolysis.
(B) Alignment of LNR-containing molecules from different metazoan and pre-metazoan 
species shows that full length Notch (with delta binding domain) is only found in metazoans, 
but that proto-Notch genes that lack the delta binding domain are found in pre-metazoans 
such as choanoflagellates and capsaspora (Gazave et al., 2009; King et al., 2008).
(C) The modularity of the synNotch receptor platform allows the user to specify the 
extracellular cues the cells now respond to, as well as the cellular responses that are induced 
downstream of receptor activation.
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